Abstract
Summary
Children living with growth hormone deficiency (GHD) are usually treated with daily injections of a growth hormone called A worldwide clinical study involving 224 children living with GHD found that weekly This analysis focused specifically on the 45 children of Asian ethnicity from this worldwide study. Asian children who received Both treatment groups had IGF-I levels that were in the normal range over 12 months of treatment. IGF-I is a hormone that works together with growth hormone to make children grow taller. Both treatments were just as safe. Most of the side effects children had during treatment were mild or moderate, and none of the children had to stop their treatment because of side effects. A side effect is a medical problem (expected or unexpected) that occurs during the study that may or may not be caused by the treatment being taken. The results from this analysis of 45 Asian children agreed with the results for the whole study group, which had 224 children. Asian children living with GHD may have better growth with weekly
This summary reports the results of a single study. The results of this study may differ from those of other studies. Health professionals should make treatment decisions based on all available evidence and not on the results of a single study.
Footnotes
Acknowledgements
Pfizer’s generative artificial intelligence (AI) assisted technology was used in the production of this plain language summary of a publication. The AI tool was used to generate some of the statements describing the disease and treatment in the first draft. After using this tool, the authors reviewed and edited the content as needed and take full responsibility for the content of the publication. Writing support for this summary was provided by Chu Kong Liew, PhD, CMPP, at Envision Pharma Group, and was funded by Pfizer. All authors of the full article were involved in preparing this summary and approved the content in the final version. OPKO Health and Pfizer would like to thank all of the people who took part in this study.
